Brown A M, Wiggins D, Gibbons G F
Oxford Lipid Metabolism Group, Metabolic Research Laboratory, Nuffield Department of Clinical Medicine, University of Oxford, Radcliffe Infirmary, Oxford, UK.
Arterioscler Thromb Vasc Biol. 1999 Feb;19(2):321-9. doi: 10.1161/01.atv.19.2.321.
Primary hepatocytes cultured in a medium supplemented with amino acids and lipogenic substrates responded to increased extracellular glucose by increasing the secretion of VLDL apoB. This effect was accompanied by an increased secretion of VLDL triacylglycerol (TAG) derived from endogenous stores. Glucose also stimulated intracellular TAG mobilization via the TAG lipolysis/esterification cycle. All these effects were abolished in the presence of mannoheptulose (MH), an inhibitor of glucose phosphorylation. Glucose also gave rise to a modest (50% to 60%) increase in the incorporation of 35S methionine into newly synthesized apoB (P<0.05) and to a doubling of newly-synthesized apoB secretion as VLDL (P<0. 05). The magnitude of these effects was similar for apoB-48 and for apoB-100. MH inhibited apoB-48 and apoB-100 synthesis and VLDL secretion at all glucose concentrations. The effects of glucose and MH on the secretion of newly-synthesized apoB-48 or apoB-100 as small dense particles were less pronounced. Glucose had no effects on the posttranslational degradation of newly-synthesized apoB-100 or apoB-48. However, this process was significantly enhanced by MH. The results suggest that glucose stimulates TAG synthesis, turnover, and output as VLDL. These effects are associated with an increased VLDL output of apoB mediated mainly by an increase in the net synthesis of both apoB-48 and apoB-100. All these changes are prevented by interference with glucose phosphorylation. Output of small, dense, apoB-containing particles is relatively unaffected by the glucose and MH-induced changes in TAG synthesis and lipolysis, an observation which suggests that only the bulk lipid addition step of VLDL assembly is affected by changes in glucose metabolism.
在补充了氨基酸和生脂底物的培养基中培养的原代肝细胞,通过增加极低密度脂蛋白载脂蛋白B(VLDL apoB)的分泌来响应细胞外葡萄糖浓度的升高。这种效应伴随着源自内源性储存的极低密度脂蛋白三酰甘油(TAG)分泌增加。葡萄糖还通过TAG脂解/酯化循环刺激细胞内TAG的动员。在存在甘露庚酮糖(MH)(一种葡萄糖磷酸化抑制剂)的情况下,所有这些效应均被消除。葡萄糖还使35S甲硫氨酸掺入新合成的apoB中的量适度增加(50%至60%)(P<0.05),并使新合成的apoB作为VLDL的分泌量增加一倍(P<0.05)。这些效应的幅度对于apoB-48和apoB-100而言相似。在所有葡萄糖浓度下,MH均抑制apoB-48和apoB-100的合成以及VLDL的分泌。葡萄糖和MH对新合成的apoB-48或apoB-100作为小而致密颗粒的分泌的影响不太明显。葡萄糖对新合成的apoB-1百或apoB-48的翻译后降解没有影响。然而,MH显著增强了这一过程。结果表明,葡萄糖刺激TAG合成、周转以及作为VLDL的输出。这些效应与主要由apoB-48和apoB-100的净合成增加介导的apoB的VLDL输出增加有关。通过干扰葡萄糖磷酸化可阻止所有这些变化。含apoB的小而致密颗粒的输出相对不受葡萄糖和MH诱导的TAG合成及脂解变化的影响,这一观察结果表明,只有VLDL组装的大量脂质添加步骤受葡萄糖代谢变化的影响。